Polymorphisms of the fibrinogen-beta gene are related to 2-hour glucose level after oral glucose tolerance test in Hong Kong Chinese

Disease Markers

Volumn 24, Issue 3, 2008, Pages 167-173

  Wong, Louisa Y F ^a   Ong, Kwok Leung ^a   Cheung, Bernard M Y ^a,c   Leung, Raymond Y H ^a   Man, Yu Bun ^b   Lam, Tai Hing ^a,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee

Author keywords

Fibrinogen; Haplotype; Impaired glucose tolerance; Polymorphism

Indexed keywords

FIBRINOGEN; GLUCOSE;

ADULT; ARTICLE; FEMALE; FIBRINOGEN BETA GENE; FIBRINOGEN BLOOD LEVEL; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HONG KONG; MIDDLE AGED; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BLOOD GLUCOSE; FEMALE; FIBRINOGEN; GENOTYPE; GLUCOSE TOLERANCE TEST; HONG KONG; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS;

EID: 44449149913     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/951894     Document Type: Article

References (28)

1. American Diabetes Association, Standards of Medical Care in Diabetes-2006, Diabetes Care 29 (2006), S4-42.
2. J.C. Barrett, B. Fry, J. Maller and M.J. Daly, Haploview: analysis and visualization of LD and haplotype maps, Bioinformatics 21 (2005), 263-265.
3. E.T. Brown and G.M. Fuller, Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism, Blood 92 (1998), 3286-3293.
4. M. Cardellini, F. Andreozzi, E. Laratta, M.A. Marini, R. Lauro, M.L. Hribal, F. Perticone and G. Sesti, Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians, Diabetes Metab Res Rev 23 (2007), 141-145.
5. J.V. Castell, M.J. Gomez-Lechon, M. David, T. Andus, T. Geiger, R. Trullenque, R. Fabra and P.C. Heinrich, Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes, FEBS Lett 242 (1989), 237-239.
6. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo, D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright, E.J. Roccella and the National High Blood Pressure Education Program Coordinating Committee, Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Hypertension 42 (2003), 1206-1252.
7. DECODE Study Group, the European Diabetes Epidemiology Group, Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria, Arch Intern Med 161 (2001), 397-405.
8. E. Ernst and K.L. Resch, Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature, Ann Intern Med 118 (1993), 956-963.
9. E.S. Ford, The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey, Atherosclerosis 168 (2003), 351-358.
10. S.E. Humphries, M. Cook, M. Dubowitz, Y. Stirling and T.W. Meade, Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations, Lancet 1 (1987), 1452-1455.
11. G. Imperatore, G. Riccardi, C. Iovine, A.A. Rivellese and O. Vaccaro, Plasma fibrinogen: a newfactor of the metabolic syndrome. A population-based study, Diabetes Care 21 (1998), 649-654.
12. E.D. Janus, N.M. Wat, K.S. Lam, S.T. Siu, L.J. Liu and T.H. Lam; the Hong Kong Cardiovascular Risk Factor Steering Committee, The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese, Diabetes Med 17 (2000), 741-745.
13. J.A. Kant, A.J. Fornace, Jr, D. Saxe, M.I. Simon, O.W. McBride and G.R. Crabtree, Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion, Proc Natl Acad Sci USA 82 (1985), 2344-2348.
14. W. Koenig, Fibrin(ogen) in cardiovascular disease: an update, Thromb Haemost 89 (2003), 601-609.
15. T.H. Lam, L.J. Liu, E.D. Janus, C. Bourke and A.J. Hedley, The relationship between fibrinogen and other coronary heart disease risk factors in a Chinese population, Atherosclerosis 143 (1999), 405-413.
16. T.H. Lam, L.J. Liu, E.D. Janus, K.S. Lam and A.J. Hedley; Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee, Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance, Diabet Med 17 (2000), 798-806.
17. A.J. Lee, G.D. Lowe, M. Woodward and H. Tunstall-Pedoe, Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study, Br Heart J 69 (1993), 338-342.
18. S. Maumus, B. Marie, M. Vincent-Viry, G. Siest and S. Visvikis-Siest, Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB -455 G/A polymorphism, Atherosclerosis 191 (2007), 369-376.
19. T. Nakagami; DECODA Study Group, Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin, Diabetologia 47 (2004), 385-394.
20. K.L. Ong, L.Y. Wong, Y.B. Man, R.Y. Leung, Y.Q. Song, K.S. Lam and B.M. Cheung, Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance, Peptides 27 (2006), 1659-1667.
21. B.L. Rodriguez, J.D. Curb, C.M. Burchfiel, B. Huang, D.S. Sharp, G.Y. Lu, W. Fujimoto and K. Yano, Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program,Diabetes Care 19 (1996), 587-590.
22. S.N. Roy, G. Mukhopadhyay and C.M. Redman, Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen, J Biol Chem 265 (1990), 6389-6393.
23. E.M. Scott, R.A. Ariens and P.J. Grant, Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease, Arterioscler Thromb Vasc Biol 24 (2004), 1558-1566.
24. G.D. Smith, R. Harbord, J. Milton, S. Ebrahim and J.A. Sterne, Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies, Arterioscler Thromb Vasc Biol 25 (2005), 2228-2233.
25. M. Stephens and P. Donelly, A comparison of Bayesian methods for haplotype reconstruction from population genotype data, Am J Hum Genet 73 (2003), 1162-1169.
26. M. Stephens, N. Smith and P. Donelly, A new statistical method for haplotype reconstruction from population data, Am J Hum Genet 68 (2001), 978-989.
27. A. Thomas, H. Lamlum, S. Humphries and F. Green, Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR, Hum Mutat 3 (1994), 79-81.
28. L.Y. Wong, R.Y. Leung, K.L. Ong and B.M. Cheung, Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension, J Hum Hypertens 21 (2007), 875-882.